ASR Vermogensbeheer’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.52M Buy
57,499
+49,865
+653% +$4.95M 0.07% 251
2026
Q1
$719K Buy
7,634
+2,033
+36% +$203K 0.01% 458
2025
Q4
$553K Sell
5,601
-68
-1% -$6.58K 0.01% 472
2025
Q3
$481K Sell
5,669
-65
-1% -$5.14K 0.01% 486
2025
Q2
$390K Sell
5,734
-30
-0.5% -$1.9K 0.01% 510
2025
Q1
$349K Buy
+5,764
New +$402K 0.01% 522

Other funds holding INCY

ASR Vermogensbeheer's INCY Position: Q2 2026 in Review

ASR Vermogensbeheer increased its Incyte (INCY) stake by 653% in Q2 2026, buying an estimated $4.95M and bringing the position to 57,499 shares worth $6.52M. The position accounts for 0.07% of the portfolio, ranked #251.

ASR Vermogensbeheer first reported a position in INCY in Q1 2025 and has held it in 6 quarters since. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • ASR Vermogensbeheer held 57,499 shares of Incyte worth $6.52M as of Q2 2026.
  • ASR Vermogensbeheer bought 49,865 Incyte shares in Q2 2026, an estimated $4.95M.
  • Incyte made up 0.07% of ASR Vermogensbeheer's portfolio in Q2 2026, its #251 holding.
  • ASR Vermogensbeheer first reported a position in Incyte in Q1 2025 and has held it in 6 quarters since.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.